SLAIN motif family member 2 pseudogene

The "SLAIN motif family member 2 pseudogene" (ENSG00000288604) is annotated as a pseudogene related to the SLAIN2 (SLAIN motif family member 2) gene. Pseudogenes are DNA sequences that resemble protein-coding genes but typically contain mutations or genomic alterations that prevent them from encoding functional proteins. They can arise via different mechanisms such as gene duplication or retrotransposition and are usually considered non-functional. However, some pseudogenes may have regulatory roles at the RNA level, but these roles are generally rare and not well characterized. The canonical SLAIN2 gene encodes a microtubule-associated protein important for microtubule organization and dynamics, but its pseudogene versions, such as ENSG00000288604, do not encode functional proteins and are not considered therapeutic targets[2][3][4]. Key context: - The original SLAIN2 gene (not the pseudogene) is involved in microtubule dynamics[1], but pseudogenes like ENSG00000288604 lack protein-coding capability due to disabling mutations[2][3]. - Pseudogenes are generally not classified as therapeutic targets, as they do not encode functional proteins and therefore do not bind drugs or perform direct biological signaling functions[2][4]. - There is no evidence in the scientific literature or databases that this specific pseudogene is involved in disease, acts as a biomarker, or has any known drug interactions or therapeutic relevance. Categorization note: - The term “pseudogene” itself means this entry is not a protein, receptor, enzyme, or any other canonical druggable target[2][3][4]. - The presence of "pseudogene" in the name, and lack of drug or functional relevance, makes this entry incorrect if a molecular drug target is required. - No abbreviation, aliases, or alternative names are used for this pseudogene in scientific resources. The molecule is best classified under "Other" or "Pseudogene" in molecular classification. Summary: This entry does not refer to a functional molecular target and should not be considered a therapeutic or biomarker target. The presence of "pseudogene" in its name and ontology indicates this, and structured resources do not list it as a target for drugs or diagnostic use[2][3][4].